Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818516 · ClinicalTrials.gov registry record · NA
Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03818516 is a NA study that has completed, run by Emory University. The registered enrollment target is 12 participants.
The verdict
NCT03818516, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study will recruit persons with schizophrenia or schizoaffective disorder and will use an oral glucose tolerance test to test the hypothesis that insulin resistance drives inflammation.
Interventions
- OTHER Oral Glucose Tolerance Test (OGTT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-08-31 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03818516
The ClinicalTrials.gov registry entry for NCT03818516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral Glucose Tolerance Test (OGTT) is the first listed.
NCT03818516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03818516 about?
NCT03818516 is a clinical study titled "Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia". This study will recruit persons with schizophrenia or schizoaffective disorder and will use an oral glucose tolerance test to test the hypothesis that insulin resistance drives inflammation.
What is the current status of trial NCT03818516?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-08-31. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT03818516?
The interventions under investigation include: Oral Glucose Tolerance Test (OGTT) (OTHER).
Who is sponsoring clinical trial NCT03818516?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.